{
    "organizations": [],
    "uuid": "aa1ab39e29b4c6732c6c26568e0d731a73ee2066",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cosmo-pharmaceuticals-receives-com/brief-cosmo-pharmaceuticals-receives-complete-response-letter-from-fda-on-methylene-blue-mmx-nda-idUSFWN1SU08C",
    "ord_in_thread": 0,
    "title": "BRIEF-Cosmo Pharmaceuticals Receives Complete Response Letter From FDA On Methylene Blue MMX NDA",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 23 (Reuters) - COSMO PHARMACEUTICALS NV:\n* RECEIVES COMPLETE RESPONSE LETTER FROM FDA ON METHYLENE BLUE MMX NDA\n* FDA DID NOT RAISE ANY SAFETY OR MANUFACTURING CONCERN * COSMO PHARMACEUTICALS - FDA DETERMINED IT CAN’T APPROVE NDA IN ITS PRESENT FORM, PROVIDES RECOMMENDATIONS NEEDED FOR RESUBMISSION\n* DOES NOT EXPECT ITS GUIDANCE FOR 2018 TO CHANGE AT THIS POINT IN TIME\n* FDA IDENTIFIED UNSPECIFIED DEFICIENCIES THAT PRECLUDE CONTINUATION OF DISCUSSION OF LABELING AND POST-MARKETING REQUIREMENT/COMMITMENTS\n* COSMO PHARMACEUTICALS THERE MIGHT NOT BE METHYLENE BLUE MMX REVENUES IN THIS YEAR, THERE ALSO WON’T BE ASSOCIATED PRODUCT LAUNCH AND SALES FORCE COSTS\n* COSMO PHARMACEUTICALS - BELIEVES CONCERNS RAISED BY FDA ARE FULLY ADDRESSABLE, WILL WORK TO HAVE MEETING WITH FDA AS QUICK AS POSSIBLE Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-05-23T13:11:00.000+03:00",
    "crawled": "2018-05-24T20:24:12.006+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "cosmo",
        "pharmaceutical",
        "nv",
        "receives",
        "complete",
        "response",
        "letter",
        "fda",
        "methylene",
        "blue",
        "mmx",
        "nda",
        "fda",
        "raise",
        "safety",
        "manufacturing",
        "concern",
        "cosmo",
        "pharmaceutical",
        "fda",
        "determined",
        "approve",
        "nda",
        "present",
        "form",
        "provides",
        "recommendation",
        "needed",
        "resubmission",
        "expect",
        "guidance",
        "change",
        "point",
        "time",
        "fda",
        "identified",
        "unspecified",
        "deficiency",
        "preclude",
        "continuation",
        "discussion",
        "labeling",
        "cosmo",
        "pharmaceutical",
        "might",
        "methylene",
        "blue",
        "mmx",
        "revenue",
        "year",
        "also",
        "associated",
        "product",
        "launch",
        "sale",
        "force",
        "cost",
        "cosmo",
        "pharmaceutical",
        "belief",
        "concern",
        "raised",
        "fda",
        "fully",
        "addressable",
        "work",
        "meeting",
        "fda",
        "quick",
        "possible",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}